Synthetic Biologics, Inc.
INTESTINAL ALKALINE PHOSPHATASE FORMULATIONS
Last updated:
Abstract:
The present invention provides for a formulation comprising an active alkaline phosphatase (AP)-based agent and an enteric agent, wherein the formulation is suitable for releasing a substantial amount of the active AP-based agent in the intestines.
Status:
Application
Type:
Utility
Filling date:
20 Mar 2019
Issue date:
4 Feb 2021